Bassem Elmankabadi, Yisheng Lee, Yuhua Li, Andrew Guarino, Wiliam Miller, Mathieu Boudreau, Benjamin Chien, Connor Peterson. "Global, phase 3, open-label, single arm studies to evaluate the efficacy, safety, and pharmacokinetics of FP-014, 11.25 mg (triptorelin mesylate injection, 11.25 mg) and FP-014, 22.5 mg (triptorelin mesylate injection, 22.5 mg) in patients with advanced prostate cancer.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.tps284